European Life Sciences Sector Remains Fragmented Despite Capital Influx
UNVERIFIED·Primary source · Sifted
Despite high-class research and talent, Europe's life sciences sector remains fragmented.
The European Investment Fund (EIF) has launched a €15bn fund of funds to support growth-stage VCs.
Health unicorn Alan raised €480m in a Series G round, valuing the company at €5.5bn.
Key Facts
01
01 — What / Thesis
European Life Sciences Sector Remains Fragmented Despite Capital Influx
02
02 — Who / Subject
European Investment Fund (EIF), Alan
03
03 — Where / Locus
Europe
04
04 — When / Temporality
July 2026
AI Verification Note
This article is generated by cross-referencing multiple sources and official announcements. Parts relying solely on testimony or reporting are reflected in the confidence score; content and assessment are updated as new information is confirmed.
